High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
CVS Health earnings surged past tepid forecasts after reporting its health benefit costs fell as a share of premiums. The pharmacy chain hiked its full-year outlook by a bit less than the Q2 beat. Analysts say that management's prudence in trying to grow its health benefits business let the company avoid the worst fallout from surprisingly strong medical care utilization.
The company lifted its adjusted EBITDA guidance to $3.8 billion–$3.9 billion, crediting savings from last year's Skydance merger
Investing.com -- Shopify Inc. (NASDAQ: SHOP) reported second-quarter results that exceeded analyst expectations on both revenue and earnings, sending shares up 26% premarket as the company delivered accelerating growth across key metrics.
NCR Voyix (VYX) delivered earnings and revenue surprises of +13.33% and +1.95%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
FTC Solar (FTCI) delivered earnings and revenue surprises of -55.10% and +6.96%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
CVS Health (CVS) delivered earnings and revenue surprises of +37.97% and +5.91%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Eli Lilly posted a blockbuster second quarter fueled by continued demand for its portfolio of GLP-1 medications. The world’s biggest drugmaker by market value reported adjusted earnings of $8.38 a share in the period, better than the $6.01 consensus estimate among analysts polled by FactSet. Revenue surged 48% to nearly $23 billion—Wall Street was looking for $20.7 billion.
Investing.com -- Eli Lilly shares jumped more than 5% in premarket trading Wednesday after the U.S. pharma giant raised its annual revenue guidance amid strong demand for its popular weight-loss and diabetes drugs.
Mounjaro revenue jumped 91% to $9.9 billion and Zepbound brought in $4.9 billion as the drugmaker beat Wall Street estimates
Uber stock fell after its Q2 results missed estimates for revenue and its growth forecast came up short of prior expectations.
AMD stock fell on Wednesday as analysts said the stock had been priced for exceptional results.
AMD stock fell on Wednesday as analysts said the stock had been priced for exceptional results.
Investing.com -- Walt Disney Co (NYSE: DIS) shares rose 4.9% premarket after the entertainment giant reported third-quarter adjusted earnings that exceeded Wall Street expectations, though revenue came in slightly below estimates.
The ride-hailing company's bookings and earnings forecasts for the current quarter came in below analyst expectations
CVS beat Wall Street expectations by a wide margin in the second quarter and raised its full-year profit forecast to as much as $8.10 per share
Investing.com -- CVS Health shares jumped about 5% in premarket trading Wednesday after the company raised its full-year profit guidance following better-than-expected second-quarter results.
Ride sharing and on-demand delivery platform Uber (NYSE:UBER) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 12.2% year on year to $14.19 billion. Its non-GAAP profit of $0.81 per share was in line with analysts’ consensus estimates.
Clear Secure (YOU) delivered earnings and revenue surprises of +22.50% and +2.91%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
NRG Energy (NYSE:NRG) reported second-quarter 2026 adjusted EBITDA of $1.2 billion, up 34% from a year earlier, while outlining plans for a 1.2-gigawatt Texas power plant intended to support a cloud and artificial intelligence hyperscaler’s data center load. President and Chief Executive Officer Ro
Some analysts see warning signs in crucial drug launches from Gilead and Merck, while an important trial readout could change Pfizer’s growth trajectory.
Kratos Defense & Security (NASDAQ:KTOS) shares jumped 7. 8% in pre-market trading after the defense technology company reported second-quarter 2026 results that comfortably exceeded Wall Street expectations and raised its growth outlook for the full year.
Autonomous driving partner Wayve received a key London license, paving the way for public robotaxi trials on the platform.
Disney's parks saw a return to growth after a slump in Q2.
Disney's revenue rose 7% to $25.2 billion in the third fiscal quarter. An increase in theme park revenue and the huge box office performance of “Toy Story 5” drove the result. Disney shares jumped premarket.
Walt Disney Co. reported a 6% bump in revenue and 21% boost in segment operating income during its fiscal third quarter earnings call on Wednesday.
(Bloomberg) -- Circle Internet Group Inc. reported second-quarter revenue that missed Wall Street expectations after circulation of its stablecoin USDC fell from a peak amid a protracted slide in cryptocurrency markets. Most Read from BloombergTrump Says Iran Talks Going Well as Hopes Rise for Hormuz DealChina’s AI Blitz Creates ‘Death Zone’ for Rival US Model MakersBeer Dynasty Families Sell €731 Million Stake in AB InBevTaco Bell Met With Michigan on Parasite Weeks Before RecallSpaceX’s AI Spl
Pinterest (NYSE:PINS) shares dropped 9. 0% in pre-market trading after the social media platform released quarterly results that exceeded expectations but issued forward guidance that failed to meet investors’ hopes.
Merck & Co., Inc. (NYSE:MRK) reported second-quarter revenue of $16.6 billion, up 5% from a year earlier, driven by oncology, animal health and contributions from newer product launches. Revenue increased 4% excluding foreign exchange, according to Chief Financial Officer Caroline Litchfield. T
Marathon Petroleum (NYSE:MPC) reported second-quarter 2026 adjusted EBITDA of $8.5 billion and earnings per share of $17.73, as strong refining margins, high utilization and crude sourcing optimization lifted results across its operations. Cash flow from operations, excluding working-capital change
McDonald's (NYSE:MCD) reported second-quarter global comparable sales growth of 1.3% and systemwide sales growth of 4% in constant currency, as positive results across all operating segments were tempered by weaker-than-expected execution in the U.S. business. Adjusted earnings per share were $3.38
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.